Jarisch R, Sandor I, Götz M, Kummer F
Hautarzt. 1979 Jul;30(7):365-70.
The results and side effects of immunotherapy in atopic dermatitis, bronchial asthma and/or allergic rhinitis are evaluated in 460 patients. The findings are listed in terms of diagnosis, age, sex and preparations as well as duration and number of incorporated allergens of immunotherapy-vaccine. In 82% a good result was reported, while in 18% no improvement could be seen. The results increase gradually from atopic dermatitis to bronchial asthma and allergic rhinitis, although the differences fail to be significant statistically. Males respond better than females. However, in bronchial asthma only, the differences are significant (p less than 0.01). According to the preparations used (Bencard, Novo-Helisen, Allpyral), no differences could be seen. The percentage of side effects is higher than 50%, but is mainly restricted to local swelling, tiredness and itching. Again no significant differences could be seen between the vaccines used.
对460例特应性皮炎、支气管哮喘和/或过敏性鼻炎患者的免疫疗法结果及副作用进行了评估。研究结果按诊断、年龄、性别、制剂以及免疫治疗疫苗中所含变应原的持续时间和数量列出。报告显示82%的患者效果良好,18%的患者未见改善。从特应性皮炎到支气管哮喘和过敏性鼻炎,结果逐渐改善,尽管差异无统计学意义。男性的反应比女性好。然而,仅在支气管哮喘中,差异具有统计学意义(p<0.01)。根据所使用的制剂(苯卡德、诺和海利森、阿吡拉),未见差异。副作用发生率高于50%,但主要局限于局部肿胀、疲劳和瘙痒。所使用的疫苗之间同样未见显著差异。